Tag Archives: USPTO

Top Ten Biotech IP Stories of 2012

I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , , , , | 2 Comments

USPTO Director Kappos Resigns

USPTO Director David Kappos has announced that he will leave the Office early next year, perhaps by the end of January. He became the Director in 2009, leaving his position as essentially Head Patent Counsel at IBM. He brought much-needed … Continue reading

Posted in People | Tagged , , , , | Leave a comment

Federal Circuit Opinion On Myriad Remand

Today, the Federal Circuit issued its opinion following GVR from the Supreme Court in AMP v. USPTO and Myriad Genetics, Inc., App. No. 2010-1406 (August 16,2012). (A copy of the opinion is available at the end of this post.) Unfortunately, … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | 1 Comment

USPTO Publishes Rule Package on AIA Administrative Trials

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading

Posted in AIA Patent Reform | Tagged , , , , , , , | Leave a comment